Search Results - "SHIMADA, AKIRA"

Refine Results
  1. 1

    Profile of down syndrome–associated malignancies: Epidemiology, clinical features and therapeutic aspects by Shimada, Akira

    Published in Pediatric hematology oncology journal (01-06-2021)
    “…Down syndrome (DS) is a congenital chromosomal abnormality caused by the presence of all or part of a third copy of chromosome 21 (+21). DS is frequently…”
    Get full text
    Journal Article
  2. 2

    Neurofibromatosis Type 1 with Concurrent Multiple Endocrine Disorders: Adenomatous Goiter, Primary Hyperparathyroidism, and Acromegaly by Yasuda, Shigemitsu, Inoue, Ikuo, Shimada, Akira

    Published in Internal Medicine (01-08-2021)
    “…We encountered a 70-year-old Japanese woman with neurofibromatosis type 1 (NF1) who had a history of pheochromocytoma and concurrently developed adenomatous…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Possible involvement of autoimmunity in fulminant type 1 diabetes by Oikawa, Yoichi, Shimada, Akira

    Published in Diabetology international (01-10-2020)
    “…Fulminant type 1 diabetes (FT1D) is characterized by a relatively low HbA1c level at the onset, despite the abrupt occurrence of marked hyperglycemia with…”
    Get full text
    Journal Article
  5. 5

    Real-world risk of cardiovascular diseases in patients with type 2 diabetes associated with sodium-glucose cotransporter 2 inhibitors in comparison with metformin: A propensity score-matched model analysis in Japan by Horii, Takeshi, Oikawa, Yoichi, Shimada, Akira, Mihara, Kiyoshi

    Published in Journal of diabetes investigation (01-11-2023)
    “…We aimed to compare the effects of cardiovascular disease risk in Japanese patients with type 2 diabetes on sodium-glucose cotransporter 2 inhibitors (SGLT2Is)…”
    Get full text
    Journal Article
  6. 6

    On‐label use of sodium–glucose cotransporter 2 inhibitors might increase the risk of diabetic ketoacidosis in patients with type 1 diabetes by Horii, Takeshi, Oikawa, Yoichi, Atsuda, Koichiro, Shimada, Akira

    Published in Journal of diabetes investigation (01-09-2021)
    “…Aims/Introduction This study aimed to investigate the risk of diabetic ketoacidosis (DKA) in insulin‐treated type 1 diabetes patients administered…”
    Get full text
    Journal Article
  7. 7

    Pharmacological inhibition of JAK3 enhances the antitumor activity of imatinib in human chronic myeloid leukemia by Yagi, Kenta, Shimada, Akira, Sendo, Toshiaki

    Published in European journal of pharmacology (15-04-2018)
    “…Imatinib (IMA) is the standard treatment for CML; however, stopping IMA sometimes results in disease relapse, which suggests that leukemic stem cells (LSCs)…”
    Get full text
    Journal Article
  8. 8

    Factor affecting severe atherothrombotic cerebral infarction in patients with type 2 diabetes mellitus: Large‐scale claim database analysis of Japan by Horii, Takeshi, Oikawa, Yoichi, Kidowaki, Kasumi, Shimada, Akira, Mihara, Kiyoshi

    Published in Journal of diabetes investigation (01-11-2024)
    “…ABSTRACT Aims This study aimed to investigate the factors associated with the exacerbation of the severity of atherothrombotic brain infarction at discharge in…”
    Get full text
    Journal Article
  9. 9

    Lupus anticoagulant-hypoprothrombinemia syndrome and immunoglobulin-A vasculitis: a report of Japanese sibling cases and review of the literature by Fujiwara, Kaori, Shimizu, Junya, Tsukahara, Hirokazu, Shimada, Akira

    Published in Rheumatology international (01-10-2019)
    “…Lupus anticoagulant-hypoprothrombinemia syndrome (LAHPS) is a rare bleeding disorder caused by antiprothrombin antibodies. LAHPS is associated with systemic…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Unique Inflammatory Changes in Exocrine and Endocrine Pancreas in Enterovirus-Induced Fulminant Type 1 Diabetes by Takita, Mikako, Jimbo, Erika, Fukui, Tomoyasu, Aida, Kaoru, Shimada, Akira, Oikawa, Yoichi, Yagihashi, Soroku, Miura, Junnosuke, Babazono, Tetsuya, Kobayashi, Tetsuro

    “…Abstract Context There are scant reports on the pathological changes of the exocrine and endocrine pancreas in fulminant type 1 diabetes mellitus (FT1DM)…”
    Get full text
    Journal Article
  12. 12

    Real‐world risk of lower‐limb amputation associated with sodium–glucose cotransporter 2 inhibitors versus metformin: A propensity score‐matched model analysis in Japan by Mizutani, Gen, Horii, Takeshi, Oikawa, Yoichi, Atsuda, Koichiro, Shimada, Akira

    Published in Journal of diabetes investigation (01-12-2022)
    “…ABSTRACT Aims/Introduction We aimed to clarify the real‐world risk of lower‐limb amputation and identify factors related to increased risk in Japanese patients…”
    Get full text
    Journal Article
  13. 13
  14. 14
  15. 15

    Clinical characteristics of anti-glutamic acid decarboxylase antibody-positive fulminant type 1 diabetes by Saito, Daigo, Oikawa, Yoichi, Mizutani, Gen, Inoue, Kazuyuki, Hatano, Masako, Inoue, Ikuo, Noda, Mitsuhiko, Shimada, Akira

    Published in ENDOCRINE JOURNAL (01-01-2019)
    “…This research aimed to examine the relationship between anti-glutamic acid decarboxylase antibody (GADA) titers and clinical parameters at onset and to clarify…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Adherence and treatment discontinuation of oral semaglutide and once‐weekly semaglutide injection at 12 month follow‐up: Japanese real‐world data by Horii, Takeshi, Masudo, Chikako, Takayanagi, Yui, Oikawa, Yoichi, Shimada, Akira, Mihara, Kiyoshi

    Published in Journal of diabetes investigation (01-11-2024)
    “…Adherence and treatment continuation rates of the glucagon‐like peptide‐1 receptor agonist (GLP‐1RA) semaglutide for both oral (O‐SEMA) and subcutaneous…”
    Get full text
    Journal Article
  18. 18

    Clinical Factors Affecting the Dose Conversion Ratio from Intravenous to Oral Tacrolimus Formulation among Pediatric Hematopoietic Stem Cell Transplantation Recipients by Kanamitsu, Kiichiro, Yorifuji, Takashi, Ishida, Hisashi, Fujiwara, Kaori, Washio, Kana, Shimada, Akira, Tsukahara, Hirokazu

    Published in Therapeutic drug monitoring (01-12-2020)
    “…Tacrolimus is converted from intravenous to oral formulation for the prophylaxis of graft-versus-host disease when patients can tolerate oral intake and…”
    Get full text
    Journal Article
  19. 19

    Association between glycemic control and patient-reported outcomes in adults with type 1 diabetes in Japan: the SAGE study subanalysis by Nishimura, Rimei, Shimada, Akira, Abiru, Norio, Matsuhisa, Munehide, Takahashi, Yoko, Ikegami, Hiroshi

    Published in Diabetology international (01-04-2024)
    “…Aims/introduction Psychosocial aspects and the quality of life (QOL) of individuals with diabetes are important for achieving glycemic control and treatment…”
    Get full text
    Journal Article
  20. 20

    Glycemic control status, diabetes management patterns, and clinical characteristics of adults with type 1 diabetes in Japan: Study of Adults’ Glycemia in T1DM subanalysis by Abiru, Norio, Shimada, Akira, Nishimura, Rimei, Matsuhisa, Munehide, Ozaki, Asuka, Ikegami, Hiroshi

    Published in Diabetology international (01-10-2021)
    “…Aims/introduction Type 1 diabetes is rare in the general Japanese population, but becoming more common in adults with increased longevity owing to advancements…”
    Get full text
    Journal Article